相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Update on Medical Management of Pulmonary Arterial Hypertension
Alexander E. Sherman et al.
CARDIOLOGY CLINICS (2022)
Current and future treatments of pulmonary arterial hypertension
Natascha Sommer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
PPARγ-p53-Mediated Vasculoregenerative Program to Reverse Pulmonary Hypertension
Jan K. Hennigs et al.
CIRCULATION RESEARCH (2021)
Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling
Shuai Zhang et al.
EXPERIMENTAL CELL RESEARCH (2021)
Endothelial Dysfunction in Pulmonary Hypertension: Cause or Consequence?
Kondababu Kurakula et al.
BIOMEDICINES (2021)
mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target
Aleksandra Babicheva et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension
Zhi Hu et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2021)
ERK/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension
Wei Feng et al.
CELL PROLIFERATION (2021)
PDGF mediates pulmonary arterial smooth muscle cell proliferation and migration by regulating NFATc2
Fang-Yun Zhao et al.
MOLECULAR MEDICINE REPORTS (2021)
miR-125a-5p inhibits glycolysis by targeting hexokinase-II to improve pulmonary arterial hypertension
Li Luo et al.
AGING-US (2020)
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ
Christoph M. Zehendner et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Guidelines for the Treatment of Pulmonary Arterial Hypertension
Zoe G. S. Vazquez et al.
LUNG (2020)
New Insights Into Heat Shock Protein 90 in the Pathogenesis of Pulmonary Arterial Hypertension
Liqing Hu et al.
FRONTIERS IN PHYSIOLOGY (2020)
Role of smooth muscle cell p53 in pulmonary arterial hypertension
Takayuki Wakasugi et al.
PLOS ONE (2019)
Multicenter Preclinical Validation of BET Inhibition for the Treatment of Pulmonary Arterial Hypertension
Diederik E. Van der Feen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Effect of domiciliary oxygen therapy on exercise capacity and quality of life in patients with pulmonary arterial or chronic thromboembolic pulmonary hypertension: a randomised, placebo-controlled trial
Silvia Ulrich et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOXand Atg-5/Atg-7/Beclin-1/LC3 beta Pathways
Yi-Chia Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
An overview of the 6th World Symposium on Pulmonary Hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
HMGB1/TLR4 promotes hypoxic pulmonary hypertension via suppressing BMPR2 signaling
Jin Wang et al.
VASCULAR PHARMACOLOGY (2019)
Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy
Ali Alqahtani et al.
FUTURE SCIENCE OA (2019)
Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension
Olivier Boucherat et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Pulmonary arterial hypertension: pathogenesis and clinical management
Thenappan Thenappan et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Targeted therapy of pulmonary arterial hypertension: Updated recommendations from the Cologne Consensus Conference 2018
Marius M. Hoeper et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Effects of toceranib compared with sorafenib on monocrotaline-induced pulmonary arterial hypertension and cardiopulmonary remodeling in rats
Zi Ping Leong et al.
VASCULAR PHARMACOLOGY (2018)
Effect of breathing oxygen-enriched air on exercise performance in patients with precapillary pulmonary hypertension: randomized, sham-controlled cross-over trial
Silvia Ulrich et al.
EUROPEAN HEART JOURNAL (2017)
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients
Evangelos D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The cancer theory of pulmonary arterial hypertension
Olivier Boucherat et al.
PULMONARY CIRCULATION (2017)
Pulmonary arterial hypertension in the USA: an epidemiological study in a large insured pediatric population
Lin Li et al.
PULMONARY CIRCULATION (2017)
PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway
Yunbin Xiao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
PPARγ Links BMP2 and TGFβ1 Pathways in Vascular Smooth Muscle Cells, Regulating Cell Proliferation and Glucose Metabolism
Laurent Calvier et al.
CELL METABOLISM (2017)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT)
Nazzareno Galie et al.
EUROPEAN HEART JOURNAL (2016)
The molecular targets of approved treatments for pulmonary arterial hypertension
Marc Humbert et al.
THORAX (2016)
Pulmonary arterial hypertension: Basic knowledge for clinicians
Diana Santos-Ribeiro et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2016)
Inhibition of heat shock protein 90 improves pulmonary arteriole remodeling in pulmonary arterial hypertension
Guo-Kun Wang et al.
ONCOTARGET (2016)
Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways
Mei-Yueh Lee et al.
SCIENTIFIC REPORTS (2016)
Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension
Haiyang Tang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2015)
BMPR2 Preserves Mitochondrial Function and DNA during Reoxygenation to Promote Endothelial Cell Survival and Reverse Pulmonary Hypertension
Isabel Diebold et al.
CELL METABOLISM (2015)
Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL)
Ioana R. Preston et al.
CIRCULATION (2015)
Bromodomain-Containing Protein 4 The Epigenetic Origin of Pulmonary Arterial Hypertension
Jolyane Meloche et al.
CIRCULATION RESEARCH (2015)
Efficacy and Safety of Exercise Training in Chronic Pulmonary Hypertension Systematic Review and Meta-Analysis
Ambarish Pandey et al.
CIRCULATION-HEART FAILURE (2015)
Evaluation of WO-2014132220, selective PDGFR inhibitors for the treatment of pulmonary arterial hypertension
Peter Norman
EXPERT OPINION ON THERAPEUTIC PATENTS (2015)
Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute
Anna R. Hemnes et al.
PULMONARY CIRCULATION (2015)
Inactivation of p53 Is Sufficient to Induce Development of Pulmonary Hypertension in Rats
S. Jacquin et al.
PLOS ONE (2015)
被撤回的出版物: p53 Modulates Hsp90 ATPase Activity and Regulates Aryl Hydrocarbon Receptor Signaling (Retracted article. See vol. 15, pg. 408, 2022)
Amit Kochhar et al.
CANCER PREVENTION RESEARCH (2014)
The Metabolic Theory of Pulmonary Arterial Hypertension
Roxane Paulin et al.
CIRCULATION RESEARCH (2014)
Rapamycin Reverses Pulmonary Artery Smooth Muscle Cell Proliferation in Pulmonary Hypertension
Amal Houssaini et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Glutamine and cancer: cell biology, physiology, and clinical opportunities
Christopher T. Hensley et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Pathogenesis of pulmonary arterial hypertension: lessons from cancer
Christophe Guignabert et al.
EUROPEAN RESPIRATORY REVIEW (2013)
Lung 18F-Fluorodeoxyglucose Positron Emission Tomography for Diagnosis and Monitoring of Pulmonary Arterial Hypertension
Glenn Marsboom et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Pregnancy outcomes in pulmonary arterial hypertension in the modern management era
Xavier Jais et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Molecular pathogenesis of pulmonary arterial hypertension
Marlene Rabinovitch
JOURNAL OF CLINICAL INVESTIGATION (2012)
p53 Gene deficiency promotes hypoxia-induced pulmonary hypertension and vascular remodeling in mice
Shiro Mizuno et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2011)
Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension
David Montani et al.
EUROPEAN HEART JOURNAL (2010)
Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells
J Wharton et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension
O Sitbon et al.
CIRCULATION (2005)
Drug therapy: Treatment of pulmonary arterial hypertension
M Humbert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Cellular and molecular pathobiology of pulmonary arterial hypertension
M Humbert et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis
MS McMurtry et al.
CIRCULATION RESEARCH (2004)
分享论文
